Foundation / Corporation
Pancreatic Cancer Action Network (PanCAN) and Celgene Corporation
12/06/19 Midnight EST
Grants to USA, Canada, and International biomedical scientists affiliated with a qualifying research, medical, or academic institution for high priority research on pancreatic cancer. Funding is intended to support research for crucial translational next steps that will apply scientific discovery to real-world application in patients. Proposed research should aim to identify novel targets and approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance.
The 2020 Pancreatic Cancer Action Network Translational Research Grant will fund high priority pancreatic cancer research that is poised for important translational next steps to help move scientific discovery to application in patients. PanCAN has partnered with the Celgene Corporation to accelerate the development of novel therapies by establishing strong relationships between academia and industry through research grants. Funded projects will benefit from industry input and insight, leading to an accelerated translation into a therapeutic product.
To be eligible for a Translational Research Grant, the research project should aim to identify novel targets and approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance. Of particular interest are research projects that fall into at least one of these three areas of research: a) Immune context and tumor microenvironment interactions, (b) Regulators of pathogenesis, progression and metabolism, with particular interest in epigenetic mechanisms and (c) Transcriptional networks essential for viability and maintenance of malignant phenotype.
Projects should be built on a strong foundation of basic research and propose steps that translate that finding into a drug or immunologic approach to the treatment of pancreatic cancer. The intent of the project should be to extensively validate novel targets and/or identify novel approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance. Translational research involving robust animal models is permitted but there is emphasis on the incorporation of human tumors or tumor-derived tissue. There is particular interest in co-development of a biomarker that can be used to identify a subset of pancreatic cancer patients most likely to respond to the proposed therapeutic intervention.
Application projects are limited to the following:
Examples of projects and use of funds:
GrantWatch ID#: 166433
It is anticipated that four Translational Research Grants will be awarded.
The Translational Research Grant provides $500,000 over two years.
The project term is two years; however, contingent on success, projects may be expanded to a third year. Expansion will be determined separately from this application. The grant term begins July 1, 2020.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Inquiries or technical issues regarding proposalCENTRAL and the online application process should be directed to customer support at:
Toll-free: (800) 875-2562
Inquiries about the 2020 Translational Research Grant guidelines and application materials should be directed to:
Valerie Holzherr, Manager, Research and Grants
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA) Guam (USA) Puerto Rico (USA) Virgin Islands (USA) Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
International country outside of the USA, Israel and Canada.